Literature DB >> 1733957

The bacteriophage phi 29 DNA polymerase, a proofreading enzyme.

C Garmendia1, A Bernad, J A Esteban, L Blanco, M Salas.   

Abstract

The bacteriophage phi 29 DNA polymerase, involved both in the protein-primed initiation and elongation steps of the viral DNA replication, displays a very processive 3',5'-exonuclease activity acting preferentially on single-stranded DNA. This exonucleolytic activity showed a marked preference for excision of a mismatched versus a correctly paired 3' terminus. These characteristics enable the phi 29 DNA polymerase to act as a proofreading enzyme. A comparative analysis of the wild-type phi 29 DNA polymerase and a mutant lacking 3',5'-exonuclease activity indicated that a productive coupling between the exonuclease and polymerase activities is necessary to prevent fixation of polymerization errors. Based on these data, the phi 29 DNA polymerase, a model enzyme for protein-primed DNA replication, appears to share the same mechanism for the editing function as that first proposed for T4 DNA polymerase and Escherichia coli DNA polymerase I on the basis of functional and structural studies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733957

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Phi29 family of phages.

Authors:  W J Meijer; J A Horcajadas; M Salas
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  Initiation of phi 29 DNA replication occurs at the second 3' nucleotide of the linear template: a sliding-back mechanism for protein-primed DNA replication.

Authors:  J Méndez; L Blanco; J A Esteban; A Bernad; M Salas
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

3.  Direct observation of translocation in individual DNA polymerase complexes.

Authors:  Joseph M Dahl; Ai H Mai; Gerald M Cherf; Nahid N Jetha; Daniel R Garalde; Andre Marziali; Mark Akeson; Hongyun Wang; Kate R Lieberman
Journal:  J Biol Chem       Date:  2012-02-29       Impact factor: 5.157

4.  Duality of polynucleotide substrates for Phi29 DNA polymerase: 3'-->5' RNase activity of the enzyme.

Authors:  Arunas Lagunavicius; Zivile Kiveryte; Vilma Zimbaite-Ruskuliene; Tomas Radzvilavicius; Arvydas Janulaitis
Journal:  RNA       Date:  2008-01-29       Impact factor: 4.942

5.  Structural and functional studies on phi 29 DNA polymerase.

Authors:  M A Blasco; J A Esteban; J Méndez; L Blanco; M Salas
Journal:  Chromosoma       Date:  1992       Impact factor: 4.316

6.  A DNA binding motif coordinating synthesis and degradation in proofreading DNA polymerases.

Authors:  V Truniger; J M Lázaro; M Salas; L Blanco
Journal:  EMBO J       Date:  1996-07-01       Impact factor: 11.598

7.  Template-dependent multiple displacement amplification for profiling human circulating RNA.

Authors:  Weihua Wang; Yi Ren; Yang Lu; Yuan Xu; Seth D Crosby; Adrian M Di Bisceglie; Xiaofeng Fan
Journal:  Biotechniques       Date:  2017-07-01       Impact factor: 1.993

8.  Role of the LEXE motif of protein-primed DNA polymerases in the interaction with the incoming nucleotide.

Authors:  Eugenia Santos; José M Lázaro; Patricia Pérez-Arnaiz; Margarita Salas; Miguel de Vega
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

9.  Whole-Genome Sequencing to Evaluate the Resistance Landscape Following Antimalarial Treatment Failure With Fosmidomycin-Clindamycin.

Authors:  Ann M Guggisberg; Sesh A Sundararaman; Miguel Lanaspa; Cinta Moraleda; Raquel González; Alfredo Mayor; Pau Cisteró; David Hutchinson; Peter G Kremsner; Beatrice H Hahn; Quique Bassat; Audrey R Odom
Journal:  J Infect Dis       Date:  2016-07-20       Impact factor: 5.226

10.  Comparative modeling of DNA and RNA polymerases from Moniliophthora perniciosa mitochondrial plasmid.

Authors:  Bruno S Andrade; Alex G Taranto; Aristóteles Góes-Neto; Angelo A Duarte
Journal:  Theor Biol Med Model       Date:  2009-09-10       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.